Synergy Spine Solutions announced today that it received FDA premarket approval (PMA) for its Synergy Disc for 1-level indications at C3-C7.

The case emphasizes Bannwarth syndrome as a rare but treatable cause of neurologic deterioration in an older woman receiving surgical cancer care.

Milestone approval advances a new category of artificial cervical disc technology uniquely engineered to preserve motion and improve spinal ...

Researcher found 80% of claim denials were ultimately reversed, reinforcing long-standing concerns raised by AAOS and patient advocates ...

A spine surgeon who practiced in Longview is facing four malpractice lawsuits from patients who said he botched their surgeries, leaving them with long-term disabilities. However, in a lawsuit against ...

Zavation Medical Products, LLC ("Zavation"), a portfolio company of Gemspring Capital and designer and manufacturer of spinal implants, interventional spine products, and biologics, announced today ...

Cardemil, Y. , Tracana, L. and Medina, F. (2026) “Nakamura-Tracana Technique Based on Newton’s Third Law Applied to Stabilize Hangman Type Iii Cervical Fracture: The First Case in Latin America”. Open ...

Q4 2025 Earnings Call February 24, 2026 5:00 PM ESTCompany ParticipantsSeth Blackley - Co-Founder, CEO & DirectorMario ...

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsPatrick Miles - Executive Chairman, CEO ...

Alphatec Holdings, Inc. (NASDAQ:ATEC) Q4 2025 Earnings Call Transcript February 24, 2026 Alphatec Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.1448 EPS, expectations were $0.04.

A woman in her 40s presented with progressive cognitive decline, expressive language difficulty and episodic confusion. Her initial symptoms were misattributed to psychiatric illness, and later to ...